EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Epstein‐Barr Virus Donor Serostatus on Post‐Transplant Mortality and Post‐Transplant Lymphoproliferative Disorder in Epstein‐Barr Virus Seropositive Thoracic Organ Transplant Recipients: Data from the Organ Procurement and Transplantation Network

Khuloud Aldhaheri iD, Robert C Wright iD, Stephen Lee iD, Mohsin Ali iD, Brian Clarke iD, Céline Bergeron iD, Allison Mah iD, Alissa Wright, Sara Belga iD

Journal of Medical Virology · 2026

DOI: 10.1002/jmv.71117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Khuloud Aldhaheri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates. Hauptthemen laut MEDLINE: Lymphoproliferative Disorders, Epstein-Barr Virus Infections, Herpesvirus 4, Human, Tissue Donors. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Donor Epstein‐Barr virus (EBV)‐seropositive (D + ) serostatus is a risk factor for post‐transplant lymphoproliferative disorder (PTLD) in EBV‐seronegative recipients. The impact of donor EBV serostatus on mortality and PTLD in EBV‐seropositive (R + ) thoracic organ transplant recipients is unknown. We analyzed 49 458 EBV R+ thoracic transplant recipients from the Organ Procurement and Transplantation Network (2004–2021). The primary exposure was EBV D+ serostatus; outcomes were death and PTLD. Associations were assessed using multivariable Cox and logistic regression models. EBV D+ serostatus was not associated with mortality but significantly reduced the hazard of PTLD in lung and heart‐lung (L/HLT) recipients (adjusted hazard ratio, 0.59; 95% CI: 0.42–0.83). No association was observed in heart transplants. Notably, 48.7% of PTLD cases in EBV R + L/HLT occurred early after transplant when the donor was EBV‐seronegative (D‐). In an exploratory subgroup analysis of PTLD cases, EBV D+ serostatus was associated with lower odds of early vs late PTLD (adjusted odds ratio [aOR]: 0.40; 95% CI: 0.22–0.73). Conversely, L/HLT had twice the odds of early PTLD (aOR: 2.62; 95% CI: 1.68 – 4.08). EBV D‐/R + L/HLT recipients carry a substantially higher risk of PTLD than EBV D + /R+ recipients, driven predominantly by early‐onset disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoproliferative DisordersEpstein-Barr Virus InfectionsHerpesvirus 4, HumanTissue DonorsTransplant RecipientsLung TransplantationOrgan TransplantationHumansFemaleMaleMiddle AgedAdultHeart TransplantationRisk FactorsTissue and Organ ProcurementAged

Stichwörter der Autor:innen

Epstein‐Barr virusLung transplantheart transplantpost‐transplant lymphoproliferative disorder

Autor:innen und Institutionen

  • Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
  • Department of Medicine, Division of Infectious Disease, University of British Columbia, Vancouver, British Columbia, Canada.
  • Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
  • Department of Medicine, Division of Infectious Diseases, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, Toronto, Ontario, Canada.

ORCID-Profile: Khuloud Aldhaheri, Robert C Wright, Stephen Lee, Mohsin Ali, Brian Clarke, Céline Bergeron, Allison Mah, Sara Belga

Zitieren

APA

Aldhaheri, K., Wright, R. C., Lee, S., Ali, M., Clarke, B., Bergeron, C., Mah, A., Wright, A., & Belga, S. (2026). Impact of Epstein‐Barr Virus Donor Serostatus on Post‐Transplant Mortality and Post‐Transplant Lymphoproliferative Disorder in Epstein‐Barr Virus Seropositive Thoracic Organ Transplant Recipients: Data from the Organ Procurement and Transplantation Network. Journal of Medical Virology. https://doi.org/10.1002/jmv.71117

Vancouver

Aldhaheri K, Wright RC, Lee S, Ali M, Clarke B, Bergeron C, et al. Impact of Epstein‐Barr Virus Donor Serostatus on Post‐Transplant Mortality and Post‐Transplant Lymphoproliferative Disorder in Epstein‐Barr Virus Seropositive Thoracic Organ Transplant Recipients: Data from the Organ Procurement and Transplantation Network. Journal of Medical Virology. 2026. doi:10.1002/jmv.71117

BibTeX
@article{Aldhaheri2026,
  author = {Aldhaheri, Khuloud and Wright, Robert C and Lee, Stephen and Ali, Mohsin and Clarke, Brian and Bergeron, Céline and Mah, Allison and Wright, Alissa and Belga, Sara},
  title = {Impact of Epstein‐Barr Virus Donor Serostatus on Post‐Transplant Mortality and Post‐Transplant Lymphoproliferative Disorder in Epstein‐Barr Virus Seropositive Thoracic Organ Transplant Recipients: Data from the Organ Procurement and Transplantation Network},
  journal = {Journal of Medical Virology},
  year = {2026},
  doi = {10.1002/jmv.71117}
}
Kostenlos starten →